Buy AROMASIN 25mg – DRAGON PHARMA Online

Description

Chemical name: (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
Formula: C20H24O2
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

AROMASIN 25mg – DRAGON PHARMA

Summary Information: AROMASIN is an oral medication manufactured by Dragon Pharma, containing the active substance Exemestane. Each tablet typically contains 25 mg of Exemestane. Exemestane is classified as an aromatase inhibitor, primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the production of estrogen in the body, thereby slowing down the growth of estrogen-dependent tumors.

Product Composition: The active pharmaceutical ingredient in AROMASIN tablets is Exemestane, a selective aromatase inhibitor. Exemestane binds irreversibly to the aromatase enzyme, inhibiting its activity and blocking the conversion of androgens into estrogen. By reducing estrogen levels in the body, Exemestane helps suppress the growth and proliferation of hormone-sensitive breast cancer cells. In addition to Exemestane, AROMASIN tablets may contain various excipients and coatings to ensure proper formulation and stability.

Manufacturer: AROMASIN tablets are manufactured by Dragon Pharma, a reputable pharmaceutical company known for producing high-quality medications and innovative pharmaceutical formulations. Dragon Pharma adheres to strict manufacturing standards to ensure product efficacy, safety, and compliance with regulatory requirements.

Package: AROMASIN tablets are typically supplied in blister packs containing 100 tablets, each with a dosage strength of 25 mg of Exemestane. The packaging may include information such as the expiration date, lot number, and manufacturer details.

Usage Instructions: AROMASIN tablets are taken orally, usually once daily, with or without food, as directed by a healthcare professional. The duration of treatment and dosage may vary depending on factors such as the stage of breast cancer, treatment response, and individual patient characteristics. It is essential to follow the prescribed regimen closely and not to exceed recommended dosages without medical supervision.

Benefits:

• Breast Cancer Treatment: AROMASIN is effective in the treatment of hormone receptor-positive breast cancer in postmenopausal women, reducing the risk of disease recurrence and improving overall survival rates.
• Aromatase Inhibition: Exemestane selectively inhibits the aromatase enzyme, leading to a significant reduction in estrogen levels in the body, which is crucial for the growth and progression of hormone-sensitive breast tumors.
• Adjuvant Therapy: AROMASIN may be used as adjuvant therapy in combination with other treatments such as surgery, chemotherapy, or radiation therapy to improve treatment outcomes and reduce the risk of cancer recurrence.
• Well-Tolerated: AROMASIN is generally well-tolerated, with manageable side effects such as hot flashes, fatigue, and musculoskeletal symptoms reported infrequently, allowing for improved treatment adherence and patient comfort.

It is important to note that AROMASIN should only be used under the supervision of a qualified healthcare professional experienced in the management of breast cancer. Patients should be monitored regularly for treatment response, estrogen levels, and potential adverse effects, and appropriate supportive care should be provided as needed throughout the course of treatment.